Last reviewed · How we verify

traditional peri-articular injection

Dezhou Hospital Qilu Hospital of Shandong University · FDA-approved active Small molecule Quality 2/100

traditional peri-articular injection is a Small molecule drug developed by Dezhou Hospital Qilu Hospital of Shandong University. It is currently FDA-approved. Also known as: Cocktail injection.

At a glance

Generic nametraditional peri-articular injection
Also known asCocktail injection
SponsorDezhou Hospital Qilu Hospital of Shandong University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about traditional peri-articular injection

What is traditional peri-articular injection?

traditional peri-articular injection is a Small molecule drug developed by Dezhou Hospital Qilu Hospital of Shandong University.

Who makes traditional peri-articular injection?

traditional peri-articular injection is developed and marketed by Dezhou Hospital Qilu Hospital of Shandong University (see full Dezhou Hospital Qilu Hospital of Shandong University pipeline at /company/dezhou-hospital-qilu-hospital-of-shandong-university).

Is traditional peri-articular injection also known as anything else?

traditional peri-articular injection is also known as Cocktail injection.

What development phase is traditional peri-articular injection in?

traditional peri-articular injection is FDA-approved (marketed).

Related